16
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      The global economic burden of asthma and chronic obstructive pulmonary disease.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Non-communicable diseases are now the number one cause of disabilities and loss of life expectancy. Among them, chronic respiratory conditions constitute a major class. The burden of chronic respiratory diseases is generally increasing across the globe, and asthma and chronic obstructive pulmonary disease (COPD) are among the main causes of mortality and morbidity. However, the direct and indirect costs of these conditions vary across jurisdictions. This article reports on recent estimates of the costs of asthma and COPD, with a focus on comparing disease burden across different regions. Overall, there is tremendous variation in per capita annual costs of asthma and COPD. However, the methodology of the cost-of-illness studies is also vastly different, making it difficult to associate differences in reported costs to differences in the true burden of asthma and COPD. Suggestions are provided towards improving the validity and comparability of future studies.

          Related collections

          Author and article information

          Journal
          Int. J. Tuberc. Lung Dis.
          The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease
          1815-7920
          1027-3719
          Jan 2016
          : 20
          : 1
          Affiliations
          [1 ] Experimental Medicine Program, Department of Medicine, Faculty of Medicine, The University of British Columbia, Vancouver, Canada.
          [2 ] Department of Medicine, Division of Respiratory Medicine, The University of British Columbia, Vancouver, Canada; Institute for HEART + LUNG Health, Department of Medicine (Respiratory Division), The University of British Columbia, Vancouver, Canada; Centre for Clinical Epidemiology and Evaluation, The University of British Columbia, Vancouver, Canada.
          [3 ] Centre for Clinical Epidemiology and Evaluation, The University of British Columbia, Vancouver, Canada.
          Article
          10.5588/ijtld.15.0472
          26688525

          Comments

          Comment on this article